Company Filing History:
Years Active: 2023-2024
Title: Matthew Lawrence Albert: Innovator in Cancer Treatment
Introduction
Matthew Lawrence Albert is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, Albert is recognized for his groundbreaking work in diagnostic and therapeutic methods.
Latest Patents
Albert's latest patents include "Diagnostic and therapeutic methods for cancer" and "Anti-CD8 antibodies and uses thereof." The first patent provides methods for patient selection and treatment using polygenic risk scores (PRSs) for dermatological autoimmune diseases. The second patent focuses on anti-CD8 antibodies that bind human CD8 without stimulating or inhibiting the activation of CD8T cells. This invention also includes methods for detecting CD8T cells in subjects and monitoring disease and treatment progress in cancer patients.
Career Highlights
Matthew Lawrence Albert is currently employed at Genentech, Inc., a leading biotechnology company. His work at Genentech has allowed him to further develop his innovative ideas and contribute to advancements in cancer therapies.
Collaborations
Albert collaborates with notable colleagues, including Zia Khan and G Scott Chandler. These partnerships enhance the research and development of new therapeutic methods in the field of oncology.
Conclusion
Matthew Lawrence Albert is a key figure in the innovation of cancer treatment, with a focus on diagnostic methods and antibody development. His contributions are paving the way for improved patient outcomes in oncology.